Hutchin Hill Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-34,204
| Closed | -$1.37M | – | 668 |
|
|
2017
Q3 | $1.37M | Buy |
+34,204
| New | +$1.37M | 0.05% | 275 |
|
|
2017
Q2 | – | Sell |
-29,400
| Closed | -$920K | – | 1023 |
|
|
2017
Q1 | $920K | Buy |
+29,400
| New | +$920K | 0.03% | 480 |
|
|
2016
Q4 | – | Sell |
-12,500
| Closed | -$309K | – | 803 |
|
|
2016
Q3 | $309K | Buy |
+12,500
| New | +$309K | 0.01% | 492 |
|
|
2015
Q4 | – | Sell |
-74,005
| Closed | -$1.04M | – | 733 |
|
|
2015
Q3 | $1.04M | Sell |
74,005
-54,295
| -42% | -$762K | 0.04% | 397 |
|
|
2015
Q2 | $2.18M | Buy |
128,300
+48,300
| +60% | +$820K | 0.06% | 289 |
|
|
2015
Q1 | $967K | Buy |
80,000
+17,600
| +28% | +$213K | 0.03% | 434 |
|
|
2014
Q4 | $518K | Buy |
+62,400
| New | +$518K | 0.02% | 433 |
|